About

Committed to improving the care and outcome of people with ependymoma through community support and research efforts.

Established in 2006, the CERN Foundation is now a designated program of the National Brain Tumor Society dedicated to improving the lives of those affected with ependymoma. Thanks to the efforts of an international network of collaborators, the CERN Foundation has been responsible for the publication of over 50 peer-reviewed papers in leading medical journals.  This body of research has greatly advanced our understanding of ependymoma and has left a lasting legacy for future investigators to build upon.

Today, the CERN Foundation continues to advance ependymoma research by supporting scientific fellowships, clinical trials, sponsoring professional conferences and symposia, and investigating risk factors for the disease. We strive to bring awareness to the rare disease and improve the outcome and care of patients through education, referral support, and supported research efforts.

The CERN Foundation is currently engaged in a range of community outreach programs and support efforts designed to have a positive impact on the lives of children and adults living with ependymoma, as well as their families and caregivers.

                                                      


In this section

History

For over fifteen years, the CERN Foundation has been at the forefront of the fight against ependymoma.

Learn More

CERN Projects

The CERN Foundation is engaged in a range of activities to support patients, caregivers, advocates and medical professionals.

Learn More

The CERN Team

The leadership team and scientific advisory board is made up of renowned experts in their field.

Learn More

Spotlight

Bringing you up-to-date on the various projects CERN Foundation members are working on.

Learn More

Fellowship

Providing support to promising postdoctoral researchers whose focus is on ependymoma research.

Learn More

Stay Informed with the CERN Newsletter

The CERN Foundation is committed to informing you with the latest ependymoma news and research. Join our mailing list for monthly updates. View all newsletters